HuGE Literature Finder
Records
1
-
9
SNPs within microRNA binding sites and the prognosis of breast cancer. Aging 2021 Feb 13 (5): 7465-7480. Zhang Liwen, Han Lu, Huang Yubei, Feng Ziwei, Wang Xin, Li Haixin, Song Fangfang, Liu Luyang, Li Junxian, Zheng Hong, Wang Peishan, Song Fengju, Chen Kex |
Somatic Mutations in LRRK2 Identify a Subset of Invasive Mammary Carcinomas Associated with High Mutation Burden. The American journal of pathology 2020 Sep . Parrilla Castellar Edgardo R, Plichta Jennifer K, Davis Richard, Gonzalez-Hunt Claudia, Sanders Laurie |
Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls. Movement disorders : official journal of the Movement Disorder Society 2019 Jul . Agalliu Ilir, Ortega Roberto A, Luciano Marta San, Mirelman Anat, Pont-Sunyer Claustre, Brockmann Kathrin, Vilas Dolores, Tolosa Eduardo, Berg Daniela, Warø Bjørg, Glickman Amanda, Raymond Deborah, Inzelberg Rivka, Ruiz-Martinez Javier, Mondragon Elisabet, Friedman Eitan, Hassin-Baer Sharon, Alcalay Roy N, Mejia-Santana Helen, Aasly Jan, Foroud Tatiana, Marder Karen, Giladi Nir, Bressman Susan, Saunders-Pullman Rach |
The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates. Journal of cellular physiology 2019 Jul 234 (7): 10918-10925. Meng Fanlu, Zhang Linlin, Ren Yaoyao, Ma Qi |
Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease. Brain and behavior 2018 Jan 8 (1): e00858. Warø Bjørg Johanne, Aasly Jan |
Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis. JAMA neurology 2015 Jan 72 (1): 58-65. Agalliu Ilir, San Luciano Marta, Mirelman Anat, Giladi Nir, Waro Bjorg, Aasly Jan, Inzelberg Rivka, Hassin-Baer Sharon, Friedman Eitan, Ruiz-Martinez Javier, Marti-Masso Jose Felix, Orr-Urtreger Avi, Bressman Susan, Saunders-Pullman Rach |
Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2. Movement disorders : official journal of the Movement Disorder Society 2014 May 29 (6): 750-5. Ruiz-Martínez Javier, de la Riva Patricia, Rodríguez-Oroz Maria C, Mondragón Rezola Elisabet, Bergareche Alberto, Gorostidi Ana, Gago Belen, Estanga Ainara, Larrañaga Nerea, Sarasqueta Cristina, López de Munain Adolfo, Martí Massó José |
The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers. Neurology 2012 Feb . Inzelberg R, Cohen OS, Aharon-Peretz J, Schlesinger I, Gershoni-Baruch R, Djaldetti R, Nitsan Z, Ephraty L, Tunkel O, Kozlova E, Inzelberg L, Kaplan N, Fixler Mehr T, Mory A, Dagan E, Schechtman E, Friedman E, Hassin-Baer S |
LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease. Movement disorders : official journal of the Movement Disorder Society 2010 Nov 25 (15): 2536-41. Saunders-Pullman Rachel, Barrett Matthew J, Stanley Kaili M, Luciano Marta San, Shanker Vicki, Severt Lawrence, Hunt Ann, Raymond Deborah, Ozelius Laurie J, Bressman Susan |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: